Cas:20601-38-1 4,4′-Bicyclohexanol manufacturer & supplier

Chemical Name:4,4′-Bicyclohexanol

CAS.NO:20601-38-1

Synonyms:1,1′-Bicyclohexyl-4,4′-diol;1,1′-Bi(cyclohexyl)-4,4′-diol;[1,1′-Bicyclohexyl]-4,4′-diol;4,4′-bicyclohexanol;4,4′-dihydroxybicyclohexyl;EINECS 243-908-4;[1,1′-Bi(cyclohexane)]-4,4′-diol;(1,1′-Bicyclohexyl)-4,4′-diol;dicyclohexyl-4,4′-diol;4,4′-Bis(cyclohexanol);4,4′-bicyclohexanediol;Bicyclohexyl<4.4′>diol;4,4′-Dihydroxydicyclohexyl;Bicyclohexylacetophenone

Molecular Formula:C₁₂H₂₂O₂

Molecular Weight:198.302

HS Code:

Physical and Chemical Properties:

Melting point:184-188ºC

Boiling point:324.2±10.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.539

PSA:40.46000

Exact Mass:198.161987

LogP:1.85

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,1′-Bicyclohexyl-4,4′-diol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bicyclohexylacetophenone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[1,1′-Bi(cyclohexane)]-4,4′-diol Use and application,Bicyclohexyl&lt technical grade,usp/ep/jp grade.

Related News: In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 4,4′-Bicyclohexanol manufacturer The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. 4,4′-Bicyclohexanol supplier For this study, researchers purchased 231 different cosmetics products in the United States and Canada and tested them for fluorine, Bruton said. 4,4′-Bicyclohexanol vendor In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 4,4′-Bicyclohexanol factory The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs.